Novo Nordisk’s weight loss drug Wegovy slashes risk of serious heart events
The findings could expand use of Wegovy and help Novo maintain its lead over Eli Lilly, whose competing weight-loss drug Zepbound was just approved in the U.S.
Altcoins are finally joining the current bitcoin rally as crypto investors turn risk-on
Altcoins were in rally mode this week after lagging bitcoin in its recent climb to new 2023 highs.
Ripple CEO says SEC has lost sight of mission to protect investors
Ripple CEO Brad Garlinghouse said he hopes the U.S. will move beyond crypto regulation by litigation to a point where federal laws are introduced by Congress.
Moody’s cuts U.S. outlook to negative, citing deficits and political polarization
The ratings agency cut its outlook on the U.S. government to negative from stable.
Shares of ed-tech company 2U plummet 57%, fall below $1 for much of day
Online education company 2U saw its stock fall to below $1 for much of the day Friday after a concerning revenue forecast.
These luxury stocks won’t lose their luster even as sales growth slows to pre-pandemic levels
Luxury stocks are seeing growth normalize from their pandemic-era highs, but analysts believe there are still promising investment opportunities in the sector.
‘T-bill and chill’: Why Jack Bogle’s strategy of ‘lazy’ investing is making a comeback
With the meme-stock rally in the review mirror, individual investors are rediscovering a philosophy made famous by Vanguard’s founder, Jack Bogle.
Oil is struggling this week but could be primed for a near-term bounce, analysts say
Brent and U.S. crude futures were trading slightly higher Friday as the markets try to settle on a price that balances demand and war fears.
Dow leaps nearly 400 points Friday, major averages notch a second week of gains: Live updates
Stocks rallied Friday, making up the ground lost in the previous session as Treasury yields stabilized.
